Meth use surges; the role of hope in stemming gambling and other addictions; and COVID’s burnout rate for treatment professionals By William…
Tag:
buprenorphine
A weekly roundup on the latest in addiction science, medicine and care By William Wagner Chronic pain and opioids—it’s a potentially toxic…
Since its landmark passage in 2016, CARA has paid at least some dividends in the Mountain State By Jason Langendorf West Virginia…
Boulder Care is among the organizations using digital technology to combat the opioid epidemic By Jason Langendorf In 2017, after reporting a…
Many U.S. counties have zero approved caregivers By Jason Langendorf Forty percent of counties in the United States had no healthcare provider…
TreatmentMagazine.com turned to Linda Richter, Ph.D., from Center on Addiction to lay out the hard science relating to substance abuse By William…
Pharma Braeburn anticipates go-ahead for extended-release opioid treatment Brixadi in 2020 By Jason Langendorf Final approval for Brixadi, an injectable, extended-release medication…
Methadone treatment giant New Seasons, formerly called Colonial Management Group, has settled a wrongful death claim out of South Carolina for a…
Addiction Treatment Industry Newswire 03/25/2014 -ATIN – In a signal that high pricing for buprenorphine-based drugs some have called monopolistic may start to…
Addiction Treatment Industry Newswire 04/29/2013 – ATIN – Despite a decidedly negative review of its Probuphine branded implantable long acting buprenorphine (Suboxone) by…
- 1
- 2